Zobrazeno 1 - 3
of 3
pro vyhledávání: '"ZHAO LI"'
Autor:
Yan D; Department of Cardiology, Jiangsu Province Hospital of Chinese Medicine.; Affiliated Hospital of Nanjing University of Chinese Medicine., Xu XR; Affiliated Hospital of Nanjing University of Chinese Medicine., Yue BW; Affiliated Hospital of Nanjing University of Chinese Medicine., Zhao LL; Affiliated Hospital of Nanjing University of Chinese Medicine., Yan SH; Affiliated Hospital of Nanjing University of Chinese Medicine.; Department of Pharmacology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China., Qian YL; Affiliated Hospital of Nanjing University of Chinese Medicine.; Department of Medicine, Jiangsu Province Hospital of Chinese Medicine.
Publikováno v:
Medicine [Medicine (Baltimore)] 2019 Oct; Vol. 98 (43), pp. e17664.
Autor:
Xing B; From the Department of Rheumatology and Clinical Immunology (BX, YFY, LDZ, LW, WJZ, HC, QJW, FLT, FCZ, XZ), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education; and Department of Epidemiology (GS), Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yin YF, Zhao LD, Wang L, Zheng WJ, Chen H, Wu QJ, Tang FL, Zhang FC, Shan G, Zhang X
Publikováno v:
Medicine [Medicine (Baltimore)] 2015 Feb; Vol. 94 (8), pp. e572.
Publikováno v:
Medicine
Background: It is unclear whether demographic characteristics and baseline use of hypoglycemic and cardiovascular drugs significantly affect the efficacy of sodium-glucose transporter 2 (SGLT2) inhibitors on cardiorenal outcomes in patients with type